Glucagon-Like Peptide 1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus. Edited by David M Nathan and Katya Rubinow, UpToDate, Wolters Kluwer, 9 Nov
The most frequently reported ocular conditions were cataract, macular degeneration, and glaucoma
It acted via non-competitive inhibition, binding to non-active sites and inducing structural rearrangements, with reduced -helical content and increased -sheet and random coil, thereby disrupting ACE function without active-site competition
It modulates the nitric oxide system, which influences blood vessel dilation and immune response
Its not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Peptide therapy involves the use of peptidesshort chains of amino acids that act as signaling molecules within the body